Blake Borgeson

Director

Blake Borgeson (Director) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales, 1 filed past the two-business-day deadline), most often in Recursion Pharmaceuticals, Inc. (RXRX). The largest single filing was $961K of RXRX (220,000 sh × $4.37, as filed), executed Dec 2 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 8 sells · 1 late

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$3.9M

shares × price, as filed

Last traded

Sep 1

Filed Sep 2

Median ADV $67.5M across their filed names

Open performance→

Volume by month

Buys $0 Sells $3.9M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 8 filings

Sector per market data · by filing · past 12 months

Most traded names

RXRX

Recursion Pharmaceuticals, Inc. RXRX · 0 buys · 8 sells 8 filings

Recent filings

RXRXSALE Recursion Pharmaceuticals, Inc. View filing → $100K
30,000 sh × $3.34
Exec Sep 1
Filed Sep 2 · 6:01 PM ET RXRXSALE Recursion Pharmaceuticals, Inc. View filing → $158K
40,000 sh × $3.96
Exec Jul 7
Filed Jul 9 · 6:04 PM ET RXRXSALE Recursion Pharmaceuticals, Inc. View filing → $110K
30,000 sh × $3.68
Exec Jun 2
Filed Jun 4 · 5:30 PM ET RXRXSALE Recursion Pharmaceuticals, Inc. View filing → $106K
30,000 sh × $3.52
Exec May 5
Filed May 7 · 5:30 PM ET RXRXSALE Recursion Pharmaceuticals, Inc. View filing → $588K
170,000 sh × $3.46
Exec Mar 3
Filed Mar 4 · 5:30 PM ET RXRXSALE Recursion Pharmaceuticals, Inc. View filing → $924K
220,000 sh × $4.20
Exec Feb 3
Filed Feb 6 · 5:30 PM ET † RXRXSALE Recursion Pharmaceuticals, Inc. View filing → $959K
220,000 sh × $4.36
Exec Jan 6
Filed Jan 8 · 5:30 PM ET RXRXSALE Recursion Pharmaceuticals, Inc. View filing → $961K
220,000 sh × $4.37
Exec Dec 2 2025
Filed Dec 4 2025 · 5:30 PM ET